MaxCyte Inc (MXCT) Ord USD0.01 (DI)
2.50p
(0.63%)
- Add to watchlist
- Create an alert
- This stock can be held in a
2.50p
(0.63%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
2.50p
(0.63%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
411.00p
411.00p
475.00p
£414.31 million
397.50p
390.00p
172.50p
n/a
15.00p (3.92%) Previous:
15.00p
4,062
n/a
1,500
Performance
| 1 week 1W | 10.83% | 1 year 1Y | 17.73% |
|---|---|---|---|
| 1 month 1M | 38.78% | 2 years 2Y | 43.8% |
| 3 months 3M | 42.5% | 3 years 3Y | 4.09% |
| 6 months 6M | 14% | 5 years 5Y | 110.55% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/07/2023 | 31/12/2022 |
|---|---|---|
| Revenue ($m) | 8.00 | 44.26 |
| Profit before tax ($m) | (11.25) | (23.57) |
| Adjusted EPS (¢): | (11.00) | (23.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
MaxCyte joins Alliance for mRNA Medicines
16 November 2023 13:57
-
MaxCyte lowers full-year guidance after weaker third quarter
5 October 2023 13:00
-
MaxCyte signs licence deal with Vittoria Biotherapeutics
10 July 2023 13:20
-
Exercise of options and PDMR dealing
4 December 2023 07:00
-
Total Voting Rights
1 December 2023 17:43
-
Exercise of options and PDMR dealing
30 November 2023 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Annual & interim reports
Annual & interim reports are not available for this stock.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.